Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia

Clinical trial NCT00001575 · COMPLETED

Trial details

NCT number: NCT00001575
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin's Disease Lymphoma, Non-Hodgkin

Start date: 1997-04-01
Primary completion: 2013-11-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.